Form D · Pharmaceuticals
Eye Therapies, LLC
Dana Point, CA · CIK 0001564439
Offering snapshot reported Dec 19, 2012 · SEC filing
- Reported sold
- $5.82M Offering amount: $5.82M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Oct 15, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 19, 2012 | Initial | $5,820,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-188646
Source: Form D, filed Dec 19, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stuart Abelson | Executive |
| John Bello | Executive |
| Jim Mccollum | Executive |
| Lee Nordan | Executive |
| Robert Rowlett | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
26933 Camino Del Estrella, 2 Nd Floor
Dana Point, CA, 92624
Dana Point, CA, 92624